Jazz Pharmaceuticals plc Stock-Based Compensation
Jazz Pharmaceuticals plc (JAZZ) reported Stock-Based Compensation of $147.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-03
- Jazz Pharmaceuticals plc share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $73.30M, a 13.64% increase year-over-year.
- Jazz Pharmaceuticals plc share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $74.50M, a 10.04% increase year-over-year.
- Jazz Pharmaceuticals plc share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $70.85M, a 0.95% increase year-over-year.
- Jazz Pharmaceuticals plc share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $88.08M, a 47.39% increase year-over-year.
- Jazz Pharmaceuticals plc share-based payment arrangement, noncash expense for fiscal 2025 was $291.13M, a 17.37% increase from fiscal 2024.
- Jazz Pharmaceuticals plc share-based payment arrangement, noncash expense for fiscal 2024 was $248.04M, a 9.35% increase from fiscal 2023.
- Jazz Pharmaceuticals plc share-based payment arrangement, noncash expense for fiscal 2023 was $226.84M, a 2.18% increase from fiscal 2022.
- Jazz Pharmaceuticals plc share-based payment arrangement, noncash expense for fiscal 2022 was $222.00M, a 17.45% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $147.80M 10-Q · filed 2026-08-03 | $218.65M derived: sum of 3 quarters · filed 2026-08-03 | $306.73M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $74.50M 10-Q · filed 2026-05-05 | $145.35M derived: sum of 2 quarters · filed 2026-05-05 | $233.43M derived: sum of 3 quarters · filed 2026-05-05 | $297.93M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $70.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $158.93M derived: sum of 2 quarters · filed 2026-02-24 | $223.43M derived: sum of 3 quarters · filed 2026-08-03 | $291.13M 10-K · filed 2026-02-24 | ||
| 2025-09-30 | $88.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $152.58M derived: sum of 2 quarters · filed 2026-08-03 | $220.28M 10-Q · filed 2025-11-05 | $290.47M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $64.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $132.20M 10-Q · filed 2026-08-03 | $132.15M 10-Q · filed 2025-08-06 | $202.39M derived: sum of 3 quarters · filed 2026-08-03 | $262.15M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | $67.70M 10-Q · filed 2026-05-05 | $67.65M 10-Q · filed 2025-05-07 | $137.89M derived: sum of 2 quarters · filed 2026-05-05 | $197.65M derived: sum of 3 quarters · filed 2026-05-05 | $254.30M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $70.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $129.95M derived: sum of 2 quarters · filed 2026-02-24 | $186.60M derived: sum of 3 quarters · filed 2026-02-24 | $248.04M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | $59.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $116.41M derived: sum of 2 quarters · filed 2025-11-05 | $177.85M 10-Q · filed 2025-11-05 | $230.80M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | $56.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $118.09M 10-Q · filed 2025-08-06 | $171.04M derived: sum of 3 quarters · filed 2026-02-24 | $227.15M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | $61.44M 10-Q · filed 2025-05-07 | $114.38M derived: sum of 2 quarters · filed 2026-02-24 | $170.50M derived: sum of 3 quarters · filed 2026-02-24 | $231.93M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | $52.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $109.06M derived: sum of 2 quarters · filed 2026-02-24 | $170.49M derived: sum of 3 quarters · filed 2026-02-24 | $226.84M 10-K · filed 2026-02-24 | ||
| 2023-09-30 | $56.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $117.55M derived: sum of 2 quarters · filed 2024-11-07 | $173.90M 10-Q · filed 2024-11-07 | $235.46M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | $61.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $117.78M 10-Q · filed 2024-08-01 | $179.34M derived: sum of 3 quarters · filed 2025-02-26 | $236.02M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | $56.35M 10-Q · filed 2024-05-02 | $117.91M derived: sum of 2 quarters · filed 2025-02-26 | $174.59M derived: sum of 3 quarters · filed 2025-02-26 | $228.28M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2022-12-31 | $61.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $118.24M derived: sum of 2 quarters · filed 2025-02-26 | $171.93M derived: sum of 3 quarters · filed 2025-02-26 | $222.00M 10-K · filed 2025-02-26 | ||
| 2022-09-30 | $56.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $110.37M derived: sum of 2 quarters · filed 2023-11-08 | $160.44M 10-Q · filed 2023-11-08 | $213.56M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $53.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $103.76M 10-Q · filed 2023-08-09 | $156.88M derived: sum of 3 quarters · filed 2024-02-28 | $210.12M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $50.07M 10-Q · filed 2023-05-10 | $103.19M derived: sum of 2 quarters · filed 2024-02-28 | $156.43M derived: sum of 3 quarters · filed 2024-02-28 | $204.59M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $53.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $106.36M derived: sum of 2 quarters · filed 2024-02-28 | $154.52M derived: sum of 3 quarters · filed 2024-02-28 | $189.01M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $53.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $101.40M derived: sum of 2 quarters · filed 2022-11-09 | $135.89M 10-Q · filed 2022-11-09 | $167.27M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $48.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $82.65M 10-Q · filed 2022-08-03 | $114.03M derived: sum of 3 quarters · filed 2023-03-01 | $144.39M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $34.48M 10-Q · filed 2022-05-04 | $65.87M derived: sum of 2 quarters · filed 2023-03-01 | $96.22M derived: sum of 3 quarters · filed 2023-03-01 | $126.83M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $31.38M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $61.74M derived: sum of 2 quarters · filed 2023-03-01 | $92.34M derived: sum of 3 quarters · filed 2023-03-01 | $121.00M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $30.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $60.96M derived: sum of 2 quarters · filed 2021-11-09 | $89.61M 10-Q · filed 2021-11-09 | $115.55M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $30.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $59.26M 10-Q · filed 2021-08-03 | $85.19M derived: sum of 3 quarters · filed 2022-03-01 | $113.98M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $28.65M 10-Q · filed 2021-05-04 | $54.59M derived: sum of 2 quarters · filed 2022-03-01 | $83.38M derived: sum of 3 quarters · filed 2022-03-01 | $111.67M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $25.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $54.72M derived: sum of 2 quarters · filed 2022-03-01 | $83.01M derived: sum of 3 quarters · filed 2022-03-01 | $110.56M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $28.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $57.07M derived: sum of 2 quarters · filed 2020-11-02 | $84.63M 10-Q · filed 2020-11-02 | $111.35M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-06-30 | $28.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $55.84M 10-Q · filed 2020-08-04 | $82.56M derived: sum of 3 quarters · filed 2021-02-23 | $107.67M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2019-03-31 | $27.55M 10-Q · filed 2020-05-05 | $54.27M derived: sum of 2 quarters · filed 2021-02-23 | $79.38M derived: sum of 3 quarters · filed 2021-02-23 | $105.69M derived: sum of 4 quarters · filed 2021-02-23 | ||
| 2018-12-31 | $26.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $51.83M derived: sum of 2 quarters · filed 2021-02-23 | $78.14M derived: sum of 3 quarters · filed 2021-02-23 | $102.44M 10-K · filed 2021-02-23 | ||
| 2018-09-30 | $25.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $51.41M derived: sum of 2 quarters · filed 2019-11-05 | $75.72M 10-Q · filed 2019-11-05 | $103.04M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | $26.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $50.62M 10-Q · filed 2019-08-06 | $77.94M derived: sum of 3 quarters · filed 2020-02-25 | $105.06M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $24.30M 10-Q · filed 2019-05-07 | $51.62M derived: sum of 2 quarters · filed 2020-02-25 | $78.75M derived: sum of 3 quarters · filed 2020-02-25 | $106.01M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | $27.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $54.45M derived: sum of 2 quarters · filed 2020-02-25 | $81.71M derived: sum of 3 quarters · filed 2020-02-25 | $106.90M 10-K · filed 2020-02-25 | ||
| 2017-09-30 | $27.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $54.39M derived: sum of 2 quarters · filed 2018-11-06 | $79.58M 10-Q · filed 2018-11-06 | $103.86M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-06-30 | $27.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $52.45M 10-Q · filed 2018-08-07 | $76.73M derived: sum of 3 quarters · filed 2019-02-26 | $101.61M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-03-31 | $25.19M 10-Q · filed 2018-05-08 | $49.47M derived: sum of 2 quarters · filed 2019-02-26 | $74.35M derived: sum of 3 quarters · filed 2019-02-26 | $99.78M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2016-12-31 | $24.28M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $49.16M derived: sum of 2 quarters · filed 2019-02-26 | $74.59M derived: sum of 3 quarters · filed 2019-02-26 | $98.77M 10-K · filed 2019-02-26 | ||
| 2016-09-30 | $24.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $50.31M derived: sum of 2 quarters · filed 2017-11-07 | $74.49M 10-Q · filed 2017-11-07 | $98.81M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-06-30 | $25.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $49.62M 10-Q · filed 2017-08-08 | $73.93M derived: sum of 3 quarters · filed 2018-02-27 | $97.05M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $24.18M 10-Q · filed 2017-05-09 | $48.50M derived: sum of 2 quarters · filed 2018-02-27 | $71.61M derived: sum of 3 quarters · filed 2018-02-27 | $94.91M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $24.32M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $47.43M derived: sum of 2 quarters · filed 2018-02-27 | $70.73M derived: sum of 3 quarters · filed 2018-02-27 | $91.55M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $23.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $46.41M derived: sum of 2 quarters · filed 2016-11-08 | $67.23M 10-Q · filed 2016-11-08 | $86.25M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $23.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $44.12M 10-Q · filed 2016-08-09 | $63.14M derived: sum of 3 quarters · filed 2017-02-28 | $81.39M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-31 | $20.82M 10-Q · filed 2016-05-10 | $39.84M derived: sum of 2 quarters · filed 2017-02-28 | $58.09M derived: sum of 3 quarters · filed 2017-02-28 | $76.64M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2014-12-31 | $19.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $37.27M derived: sum of 2 quarters · filed 2017-02-28 | $55.82M derived: sum of 3 quarters · filed 2017-02-28 | $69.64M 10-K · filed 2017-02-28 | ||
| 2014-09-30 | $18.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $36.80M derived: sum of 2 quarters · filed 2015-11-09 | $50.62M 10-Q · filed 2015-11-09 | $63.03M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-06-30 | $18.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $32.37M 10-Q · filed 2015-08-05 | $44.78M derived: sum of 3 quarters · filed 2016-02-23 | $56.66M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-03-31 | $13.81M 10-Q · filed 2015-05-07 | $26.23M derived: sum of 2 quarters · filed 2016-02-23 | $38.10M derived: sum of 3 quarters · filed 2016-02-23 | $49.61M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2013-12-31 | $12.41M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $24.29M derived: sum of 2 quarters · filed 2016-02-23 | $35.79M derived: sum of 3 quarters · filed 2016-02-23 | $44.55M 10-K · filed 2016-02-23 | ||
| 2013-09-30 | $11.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $23.38M derived: sum of 2 quarters · filed 2014-11-04 | $32.14M 10-Q · filed 2014-11-04 | $39.99M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $11.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $20.26M 10-Q · filed 2014-08-05 | $28.12M derived: sum of 3 quarters · filed 2015-02-24 | $34.73M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | $8.76M 10-Q · filed 2014-05-08 | $16.61M derived: sum of 2 quarters · filed 2015-02-24 | $23.22M derived: sum of 3 quarters · filed 2015-02-24 | $28.48M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2012-12-31 | $7.86M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $14.47M derived: sum of 2 quarters · filed 2015-02-24 | $19.73M derived: sum of 3 quarters · filed 2015-02-24 | $23.01M 10-K · filed 2015-02-24 | ||
| 2012-09-30 | $6.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $11.87M derived: sum of 2 quarters · filed 2013-11-05 | $15.15M 10-Q · filed 2013-11-05 | $26.10M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-06-30 | $5.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $8.54M 10-Q · filed 2013-08-06 | $19.48M derived: sum of 3 quarters · filed 2014-02-25 | $22.68M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-03-31 | $3.28M 10-Q · filed 2013-05-07 | $14.23M derived: sum of 2 quarters · filed 2014-02-25 | $17.42M derived: sum of 3 quarters · filed 2014-02-25 | $20.84M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2011-12-31 | $10.95M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $14.14M derived: sum of 2 quarters · filed 2014-02-25 | $17.56M derived: sum of 3 quarters · filed 2014-02-25 | $20.70M 10-K · filed 2014-02-25 | ||
| 2011-09-30 | $3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $6.61M derived: sum of 2 quarters · filed 2012-11-09 | $9.76M 10-Q · filed 2012-11-09 | $12.01M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-06-30 | $3.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $6.56M 10-Q · filed 2012-08-07 | $8.81M derived: sum of 3 quarters · filed 2013-02-26 | $10.99M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-03-31 | $3.15M 10-Q · filed 2012-05-08 | $5.40M derived: sum of 2 quarters · filed 2013-02-26 | $7.58M derived: sum of 3 quarters · filed 2013-02-26 | |||
| 2010-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $4.43M derived: sum of 2 quarters · filed 2013-02-26 | $8.22M 10-K · filed 2013-02-26 | |||
| 2010-09-30 | $2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $5.97M 10-Q · filed 2011-11-08 | ||||
| 2010-06-30 | $3.79M 10-Q · filed 2011-08-03 | |||||
| 2009-12-31 | $5.96M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |